Cleared Special

ALERE BINAXNOW INFLUENZA A & B CARD

Dec 2013
Decision
28d
Days
Class 1
Risk

About This 510(k) Submission

K133411 is an FDA 510(k) clearance for the ALERE BINAXNOW INFLUENZA A & B CARD, a Antigens, Cf (including Cf Control), Influenza Virus A, B, C (Class I — General Controls, product code GNX), submitted by Alere Scarborough, Inc D/B/A Binax, Inc. (Scarborough, US). The FDA issued a Cleared decision on December 5, 2013, 28 days after receiving the submission on November 7, 2013. This device falls under the Microbiology review panel. Regulated under 21 CFR 866.3330.

Submission Details

510(k) Number K133411 FDA.gov
FDA Decision Cleared SESE
Date Received November 07, 2013
Decision Date December 05, 2013
Days to Decision 28 days
Submission Type Special
Review Panel Microbiology (MI)
Summary Summary PDF

Device Classification

Product Code GNX — Antigens, Cf (including Cf Control), Influenza Virus A, B, C
Device Class Class I — General Controls
CFR Regulation 21 CFR 866.3330